- Autores: De Magalhães JL, do Carmo MVS, Hartz Z
- Ano de Publicação: 2018
- Journal: Handbook of Research on Strategic Innovation Management for Improved Competitive Advantage
- Link: https://www.igi-global.com/chapter/knowledge-management-in-biotechnology-drugs-in-brazil-as-a-case-study-of-the-national-pharmaceuticals-laboratories/204245
The informational age in the twenty-first century is also known as the age of knowledge. The great differential of organizations has been the strategic innovation through the best way to manage the existing knowledge. The pharmaceutical area is one of the most intensive areas in research, development, and innovation. In this century, the discovery of new drugs and biotechnology drugs has revolutionized several treatments for human health. It is estimated that in 2017 the medical prescriptions of biotech drugs will exceed US $220 billion. It was identified that by the year 2019, several biotechnological patents will be expired in the world. New structures and strategic innovations in the scientific and technological environment of the Brazilian pharmaceutical area have occurred. There is a boom in investment opportunities in the industry through strategic innovation fostered by the updating of Brazilian legislation and investments by private companies. Knowledge management in biotechnological drugs has favored scientific, technological, and market growth in Brazilian organizations.